THE RESEARCH
NasoLume uses 650nm red light, a wavelength that has been studied in low-level light therapy research. Below are published papers for anyone who wants to read the science themselves.
For general information only. These studies were not carried out on NasoLume and are not claims about this product. NasoLume is a wellness product.
Published research
Narrow-band red light phototherapy in perennial allergic rhinitis and nasal polyposis
Annals of Allergy, Asthma & Immunology, 1997
A double-blind, randomised study with a sham-light control group, using 660nm red light from LED probes in 90 participants.
Phototherapy in Allergic Rhinitis: From In Vitro Studies to Clinical Trials
Medical Lasers, 2020
A narrative review of laboratory, animal and clinical research on different light wavelengths, including red and near-infrared.
Mechanisms and Comparative Treatments of Allergic Rhinitis including Phototherapy
Allergies (MDPI), 2024
A review discussing visible and near-infrared light, including 660nm and 940nm, and proposed mechanisms.
Low-Level Laser Therapy for Allergic Rhinitis: A Systematic Review and Meta-Analysis
International Archives of Allergy and Immunology, 2024
Pools 16 studies using light at 630–940nm. The authors report very few adverse events and call for larger, better-controlled trials.